2.09
-0.1(-4.57%)
Currency In USD
Address
2000 Frontis Plaza Blvd.
Winston-Salem, NC 27103
United States of America
Phone
336 999 7028
Website
Sector
Healthcare
Industry
Biotechnology
Employees
204
First IPO Date
June 30, 2021
| Name | Title | Pay | Year Born |
| Bruce Culleton | Chief Executive Officer & Director | 1.02M | 1968 |
| James Coulston | Chief Financial Officer | 533,152 | 1977 |
| Ulrich Ernst | EVice President of Science and Technology | 622,743 | 1963 |
| Todd C. Girolamo | Chief Legal Officer & Secretary | 635,858 | 1965 |
| Darin J. Weber | Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access | 0 | 1968 |
| Joseph Stavas | SVP of Clinical Affairs | 0 | N/A |
| Nikhil L. Pereira-Kamath | Chief Business Officer | 0 | N/A |
| Richard Williams | Chief Information Officer | 0 | N/A |
| Anu Biswas | Senior VP of Manufacturing & Operations | 0 | N/A |
| Carla Poulson | Chief People Officer | 0 | N/A |
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.